Search research articles
Contact Us
Filters
Showing results (81-90 of 92) with videos related to
Page
of 10
Sort By:
Journal of Clinical Pharmacology
|
June 27, 2000
Extravascular administration of interferon alfa-N3 increases serum exposure and 2-5(A) synthetase activity
M G Sturgill, A Rashidbaigi, M J Liao, et al.
Lancet (London, England)
|
October 19, 1996
Effect of anaemia and cardiovascular disease on surgical mortality and morbidity
J L Carson, A Duff, R M Poses, et al.
Archives of Environmental Health
|
January 1, 1984
Spontaneous abortions, stillbirths, and birth defects in families of agricultural pilots
C C Roan, G E Matanoski, C Q McIlnay, et al.
Journal of Clinical Pharmacology
|
September 1, 1996
Effects of yohimbine on autonomic measures are determined by individual values for area under the concentration-time curve
K Grasing, M G Sturgill, R C Rosen, et al.
Journal of Cardiovascular Pharmacology
|
June 1, 1997
Yohimbine elimination in normal volunteers is characterized by both one- and two-compartment behavior
M G Sturgill, K W Grasing, R C Rosen, et al.
JAMA
|
January 22, 1988
Natural interferon alfa for treatment of condylomata acuminata
A E Friedman-Kien, L J Eron, M Conant, et al.
Alimentary Pharmacology & Therapeutics
|
December 21, 2004
Ultrase MT12 and Ultrase MT20 in the treatment of exocrine pancreatic insufficiency in cystic fibrosis: safety and efficacy
M W Konstan, R C Stern, J R Trout, et al.
Infection and Immunity
|
February 1, 1993
Immunity and responses of circulating leukocytes and lymphocytes in monkeys to aerosolized staphylococcal enterotoxin B
J Tseng, J L Komisar, J Y Chen, et al.
Neonatology
|
May 18, 2021
Diamond-Blackfan Anemia: A Case Report and Review of the Literature
Kaitlyn M Dorn, Kaitlyn D Burns, Maija A R Trout, et al.
Investigational New Drugs
|
March 18, 2017
A randomized, open-label, multicenter, phase II study evaluating the efficacy and safety of BTH1677 (1,3-1,6 beta glucan; Imprime PGG) in combination with cetuximab and chemotherapy in patients with advanced non-small cell lung cancer
M Thomas, P Sadjadian, J Kollmeier, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 92) with videos related to
Sort By:
Page
of 10
Journal of Clinical Pharmacology
|
June 27, 2000
Extravascular administration of interferon alfa-N3 increases serum exposure and 2-5(A) synthetase activity
M G Sturgill, A Rashidbaigi, M J Liao, et al.
Lancet (London, England)
|
October 19, 1996
Effect of anaemia and cardiovascular disease on surgical mortality and morbidity
J L Carson, A Duff, R M Poses, et al.
Archives of Environmental Health
|
January 1, 1984
Spontaneous abortions, stillbirths, and birth defects in families of agricultural pilots
C C Roan, G E Matanoski, C Q McIlnay, et al.
Journal of Clinical Pharmacology
|
September 1, 1996
Effects of yohimbine on autonomic measures are determined by individual values for area under the concentration-time curve
K Grasing, M G Sturgill, R C Rosen, et al.
Journal of Cardiovascular Pharmacology
|
June 1, 1997
Yohimbine elimination in normal volunteers is characterized by both one- and two-compartment behavior
M G Sturgill, K W Grasing, R C Rosen, et al.
JAMA
|
January 22, 1988
Natural interferon alfa for treatment of condylomata acuminata
A E Friedman-Kien, L J Eron, M Conant, et al.
Alimentary Pharmacology & Therapeutics
|
December 21, 2004
Ultrase MT12 and Ultrase MT20 in the treatment of exocrine pancreatic insufficiency in cystic fibrosis: safety and efficacy
M W Konstan, R C Stern, J R Trout, et al.
Infection and Immunity
|
February 1, 1993
Immunity and responses of circulating leukocytes and lymphocytes in monkeys to aerosolized staphylococcal enterotoxin B
J Tseng, J L Komisar, J Y Chen, et al.
Neonatology
|
May 18, 2021
Diamond-Blackfan Anemia: A Case Report and Review of the Literature
Kaitlyn M Dorn, Kaitlyn D Burns, Maija A R Trout, et al.
Investigational New Drugs
|
March 18, 2017
A randomized, open-label, multicenter, phase II study evaluating the efficacy and safety of BTH1677 (1,3-1,6 beta glucan; Imprime PGG) in combination with cetuximab and chemotherapy in patients with advanced non-small cell lung cancer
M Thomas, P Sadjadian, J Kollmeier, et al.
Page
of 10